Serum 25-hydroxy vitamin D level is associated with elastography-detected liver fibrosis in patients with type 2 diabetes mellitus in China

Serum 25-hydroxy vitamin D level is associated with elastography-detected liver fibrosis in patients with type 2 diabetes mellitus in China

ObjectiveIn this cross-sectional study including patients with type 2 diabetes mellitus (T2DM) we aimed to explore the relationship between serum 25-hydroxy vitamin (25(OH)D) level and liver steatosis and fibrosis in the Chinese population.MethodsPatients visiting 16 clinical centers with T2DM were...

Full description

Saved in:

Bibliographic Details
Main Authors:	Nan Huang, Xianghui Su, Ting Yu, Xiaodong Wu, Bing Lu, Weixia Sun, Liqin Yao, Maoyun Wang, Yao Wang, Wenxuan Wu, Yingzhao Liu, Ting Yang, Ruidong Gao, Congqing Miao, Ling Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-11-01
Series:	Frontiers in Endocrinology
Subjects:	type 2 diabetes mellitus 25-hydroxy vitamin D liver steatosis liver fibrosis body mass index
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2024.1420088/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Increased risk of vascular complications in patients with type 2 diabetes and fatty liver disease
by: Weixia Sun, et al.
Published: (2024-11-01)

Evaluation of hepatic steatosis in obese children and adolescents using immune-inflammatory markers and shear wave elastography
by: Akçiçek Mehmet, et al.
Published: (2025-01-01)

Curcumin Prevents Free Fatty Acid-Induced Lipid Accumulation via Targeting the miR-22-3p/ CRLS1 Pathway in HepG2 Cells
by: Yuanyuan Mei, et al.
Published: (2024-02-01)

Relation between 25-hydroxy vitamin D and diabetic retinopathy in Egyptian patients with type 2 diabetes mellitus
by: Mervat E. Elwakeel, et al.
Published: (2024-01-01)

Is There a Role of 25-Hydroxy Vitamin D in the Pathogenesis of Mild and Moderate-to-Severe Endometriosis?
by: Nevin Tuten, et al.
Published: (2021-08-01)

Efficacy and Safety of Bicyclol Treatment for Non-Alcoholic Fatty Liver Disease: Results of a Cohort Study
by: I. Yu. Pirogova, et al.
Published: (2018-09-01)

Advanced Imaging Techniques for Assessing Fat, Iron, and Fibrosis in Chronic Liver Disease
by: Sabarish Narayanasamy, et al.
Published: (2025-01-01)

Prevalence of Clinically Significant Liver Fibrosis as Measured by Transient Elastography due to Non-alcoholic Fatty Liver Disease in Indian Individuals with Type 2 Diabetes Mellitus
by: Rajat Deb
Published: (2024-08-01)

Potential alternative and novel biomarkers for paediatric MAFLD: exploratory evidence from a Chinese cohort
by: Fan Yang, et al.
Published: (2025-01-01)

Detectability of Liver Steatosis and Fibrosis with Transient Elastography and Controlled Attenuation Parameter in Residents of St. Petersburg
by: V. P. Kovyazina, et al.
Published: (2021-04-01)

Microfluidic Nanobioplatform-Based Immunosensor for Monitoring of 25-Hydroxy Vitamin-D3
by: Deepika Chauhan, et al.
Published: (2024-01-01)

The Relationship Between Serum 25 hydroxy Vitamin D Deficiency and Dietary Pattern in Baxshin Hospital, Sulaimani City
by: Mohammed I M Gubari, et al.
Published: (2018-07-01)

Optimized methods to image hepatic lipid droplets in zebrafish larvae
by: Nouf Khan, et al.
Published: (2024-11-01)

Quantitative ultrasound for steatosis assessment using Hepatoscope®: Confounding technical factors
by: Adrien Besson, et al.
Published: (2024-12-01)

Assessing the diagnostic accuracy of radiological and histological findings in the diagnosis of non-alcoholic fatty liver disease stages among patients in a tertiary hospital
by: Ekpe Edemekong L, et al.
Published: (2024-07-01)

Metabolic dysfunction-associated liver disease and biliary lithiasis in children with Down Syndrome: a retrospective study
by: Renato Nisihara, et al.
Published: (2025-01-01)

Positive association between proinsulin and fatty liver index in people with type 2 diabetes
by: Akinobu Nakamura, et al.
Published: (2024-02-01)

Association of time to start of enteral nutrition and outcome in cats with hepatic lipidosis
by: Olivia P. Wallace, et al.
Published: (2024-11-01)

miRNAs and Hematological Markers in Non-Alcoholic Fatty Liver Disease—A New Diagnostic Path?
by: Agata Michalak, et al.
Published: (2025-01-01)

Metabolic dysfunction‐associated steatotic liver disease: A superior predictor for incident type 2 diabetes over traditional criteria – NAGALA study
by: Kimiko Sakai, et al.
Published: (2024-12-01)

Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Emidio Scarpellini, et al.
Published: (2024-11-01)

Features of eating behavior in children with different forms of non-alcoholic fatty liver disease
by: Yu.M. Stepanov, et al.
Published: (2021-09-01)

Noninvasive assessment of nonalcoholic fatty liver disease
by: Gajanan A Rodge, et al.
Published: (2021-01-01)

Hepatoprotective Activity of Ezetimibe Against Risperidone-Induced Liver Injury in Rats
by: Atheer Majid Rashid Al-Juhaishi, et al.
Published: (2024-07-01)

Does metabolic dysfunction-associated fatty liver disease increase the risk of chronic kidney disease? A meta-analysis of cohort studies
by: Wanghao Liu, et al.
Published: (2024-12-01)

Ethyltoluenes Regulate Inflammatory and Cell Fibrosis Signaling in the Liver Cell Model
by: Suryakant Niture, et al.
Published: (2024-11-01)

A positive relationship between weight-adjusted waist index and non-alcoholic fatty liver disease: a study on US adolescents
by: Xiaoling Cui, et al.
Published: (2025-01-01)

Association of exposure to multiple volatile organic compounds with ultrasound-defined hepatic steatosis and fibrosis in the adult US population: NHANES 2017–2020
by: Wentao Shao, et al.
Published: (2025-01-01)

Impact of shear wave elastography and attenuation imaging for predicting life-threatening event in patients with metabolic dysfunction-associated steatotic liver disease
by: Yudai Fujiwara, et al.
Published: (2025-02-01)

Large annotated ultrasound dataset of non-alcoholic fatty liver from Saudi hospitals for analysis and applicationsOpen Science framework or (OSF)
by: Fahad Alshagathrh, et al.
Published: (2025-02-01)

Determination of the effect of danofloxacin on 8-hydroxy-2-deoxyguanosine level
by: Devran Coşkun, et al.

MetALD: Clinical aspects, pathophysiology and treatmentKeypoints
by: Jordi Gratacós-Ginès, et al.
Published: (2025-02-01)

Steatotic liver disease in people with HIV at Tshepong Hospital: A post-mortem analysis
by: Aqeela Moosa, et al.
Published: (2024-12-01)

Prevalence of Liver Steatosis Among Workers in Ouagadougou and Associated Factors: A Cross‐Sectional Study
by: Delphine Napon‐Zongo, et al.
Published: (2024-12-01)

Improvement of non-alcoholic fatty liver disease treatment
by: P. I. Seliverstov, et al.
Published: (2014-10-01)

Two-Dimensional Shear-Wave Elastography: Accuracy in Liver Fibrosis Staging Using Magnetic Resonance Elastography as the Reference Standard
by: Puwitch Charoenchue, et al.
Published: (2024-12-01)

Noninvasive Imaging Test to Assess Liver Fibrosis: Vibration-controlled Transient Elastography
by: Mi Na Kim
Published: (2024-11-01)

Sodium-glucose cotransporter-2 inhibitors improve liver enzymes in patients with co-existing non-alcoholic fatty liver disease: a systematic review and metanalysis
by: Waseem Amjad, et al.
Published: (2022-01-01)

Consistency analysis of two US techniques for evaluating hepatic steatosis in patients with metabolic dysfunction-associated steatotic liver disease
by: Fei Chen, et al.
Published: (2025-01-01)

Noninvasive Assessment of Liver Fibrosis by Magnetic Resonance Elastography in Patients with Rheumatic Disease on Long-Term Methotrexate Treatment
by: Arindam Nandy Roy, et al.
Published: (2023-01-01)